$50.70
-0.2-0.39%
Pre-Market: 12:37 AM EDT
15 minutes delayed
Comments
Loading...
Viking Therapeutics
VKTXNASDAQ
Viking Therapeutics (NASDAQ:VKTX) Stock, Insider Trading Activity
Viking Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Viking Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On May 3, 2024, GREG ZANTE, the company's CHIEF FINANCIAL OFFICER sold 32.51K shares for $39.77 each.
Ownership Statistics for Viking Therapeutics Inc
Institutional Shares Held
60.459M
Institutional Percentage Held
54.8%
| May 03, 2024 | GREG ZANTE | CHIEF FINANCIAL OFFICER | -32.51K | $39.77 | -$4.82M | SELL | -15.68% | 174.85K | May 03 | View |
| May 02, 2024 | Marianna Mancini | CHIEF OPERATING OFFICER | 0.00 | $42.42 | -$20.40M | SELL-OPTIONS | 0.00% | 348.51K | May 01 | View |
| Feb 09, 2024 | Brian Lian | PRESIDENT & CEO | -45.00K | $29.90 | -$1.35M | SELL | -2.06% | 2.14M | Feb 09 | View |
| Feb 08, 2024 | Brian Lian | PRESIDENT & CEO | -80.00K | $15.32 | -$6.52M | SELL | -3.53% | 2.18M | Feb 08 | View |
| Feb 08, 2024 | Kathryn Sarah Rouan | DIRECTOR | 0.00 | $18.19 | -$493.25K | SELL-OPTIONS | 0.00% | 0.00 | Feb 08 | View |
| Jan 31, 2024 | Brian Lian | PRESIDENT & CEO | 0.00 | $12.97 | -$2.00M | SELL-OPTIONS | 0.00% | 2.26M | Jan 31 | View |
| Jan 30, 2024 | Brian Lian | PRESIDENT & CEO | 0.00 | $12.59 | -$795.20K | SELL-OPTIONS | 0.00% | 2.26M | Jan 30 | View |
| Jan 19, 2024 | Kathryn Sarah Rouan | DIRECTOR | 0.00 | $15.69 | -$441.90K | SELL-OPTIONS | 0.00% | 0.00 | Jan 19 | View |
| Jan 04, 2024 | GREG ZANTE | CHIEF FINANCIAL OFFICER | 20.34K | $17.71 | -$1.38M | GRANT | 12.68% | 180.73K | Jan 03 - Jan 04 | View |
| May 18, 2023 | Charles Rowland Jr | DIRECTOR | 0.00 | $13.04 | -$956.80K | SELL-OPTIONS | 0.00% | 30.00K | May 16 | View |
| May 18, 2023 | LAWSON MACARTNEY | DIRECTOR | 0.00 | $12.60 | -$364.96K | SELL-OPTIONS | 0.00% | 47.97K | May 16 | View |
| May 01, 2023 | Brian Lian | PRESIDENT & CEO | -45.00K | $22.45 | -$1.01M | SELL | -2.01% | 2.20M | May 01 | View |
| Apr 24, 2023 | LAWSON MACARTNEY | DIRECTOR | 0.00 | $12.67 | -$298.78K | SELL-OPTIONS | 0.00% | 47.97K | Apr 24 | View |
| Apr 21, 2023 | Brian Lian | PRESIDENT & CEO | -35.00K | $21.45 | -$750.75K | SELL | -1.54% | 2.24M | Apr 19 | View |
| Apr 18, 2023 | LAWSON MACARTNEY | DIRECTOR | 0.00 | $14.00 | -$249.43K | SELL-OPTIONS | 0.00% | 47.97K | Apr 17 | View |
| Apr 18, 2023 | Brian Lian | PRESIDENT & CEO | -30.00K | $11.30 | -$2.90M | SELL | -1.30% | 2.28M | Apr 17 | View |
| Apr 18, 2023 | Marianna Mancini | CHIEF OPERATING OFFICER | 0.00 | $16.54 | -$86.63K | SELL-OPTIONS | 0.00% | 287.76K | Apr 17 | View |
| Apr 18, 2023 | GREG ZANTE | CHIEF FINANCIAL OFFICER | 0.00 | $16.54 | -$51.98K | SELL-OPTIONS | 0.00% | 149.28K | Apr 17 | View |
| Apr 13, 2023 | Brian Lian | PRESIDENT & CEO | -25.00K | $10.16 | -$1.36M | SELL | -1.07% | 2.31M | Apr 13 | View |
| Apr 13, 2023 | GREG ZANTE | CHIEF FINANCIAL OFFICER | 0.00 | $11.79 | -$1.22M | SELL-OPTIONS | 0.00% | 149.28K | Apr 11 - Apr 12 | View |
| Apr 03, 2023 | Brian Lian | PRESIDENT & CEO | 60.00K | $11.10 | -$6.75M | SELL-OPTIONS | 2.64% | 2.33M | Mar 30 - Apr 03 | View |
| Apr 03, 2023 | GREG ZANTE | CHIEF FINANCIAL OFFICER | -35.78K | $12.35 | -$2.83M | SELL | -19.33% | 149.28K | Mar 30 - Apr 03 | View |
| Mar 30, 2023 | Marianna Mancini | CHIEF OPERATING OFFICER | -55.38K | $9.05 | -$3.07M | SELL | -17.45% | 261.89K | Mar 28 - Mar 29 | View |
| May 03, 2022 | MATTHEW FOEHR | DIRECTOR | 45.00K | $2.47 | $111.19K | BUY | 67.92% | 111.25K | May 02 | View |
| Jun 10, 2021 | MATTHEW FOEHR | DIRECTOR | 20.00K | $5.69 | $113.80K | BUY | 43.24% | 66.25K | Jun 10 | View |
| Aug 27, 2020 | LIGAND PHARMACEUTICALS INC | — | -164.49K | $8.07 | -$1.33M | SELL | -2.75% | 5.82M | Aug 25 - Aug 26 | View |
| Jun 30, 2020 | MATTHEW FOEHR | — | -13.00K | $7.35 | -$95.55K | SELL | -33.12% | 26.25K | Jun 30 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.